ANEB

Anebulo Pharmaceuticals, Inc.

HealthcareBiotechnologyUSUSDPeers →via fmp_bulk

$0.40

LiveJun 11, 2026

AI Brief

Market cap

$16.31M

52w range

0.30 – 3.42

P / E

—

EPS

—

Volume

845

Revenue · FY

—

Overview Fundamentals Market Narrative & AI

Explain this page

Arphra AIPlain-English read on Anebulo Pharmaceuticals, Inc.’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$0.40

Change

-58.21%

Period high

$1.07

Period low

$0.33

Period start

$0.962026-02-02

Through 2026-06-10

Fair value

Football field →

Weighted blend

—

— vs spot

Recommendation

n/a

0 of 0 methods

Method spread

0bull0bear

±5% threshold

Analyst PT consensus: $6.00 (+1400.19%)

Price change · trailing returns

Live

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
-0.01%	+6.65%	-13.05%	-16.68%	-82.15%	-60.40%	-65.52%	-84.00%	-95.15%	-94.37%	-94.37%

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Aftermarket

Live

Jun 11, 02:04 PM

Last trade

$0.40

Bid

$0.39

2,500 sh

Ask

$0.40

2,500 sh

Spread

$0.010

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Sector & industry today

Live

Sectors

Utilities
+1.18%
Healthcare
+1.06%
Industrials
+0.86%
Basic Materials
+0.60%
Technology
+0.11%
Consumer Cyclical
-0.01%
Financial Services
-0.19%
Consumer Defensive
-0.24%
Energy
-0.66%
Real Estate
-0.69%
Communication Services
-0.77%

Top industries (issuer's industry highlighted)

Biotechnology
+1.00%
Solar
+5.22%
Internet Content & Information
-2.59%
Engineering & Construction
+2.43%
Manufacturing - Metal Fabrication
+2.34%
Travel Services
+2.22%
Renewable Utilities
+2.12%
Copper
+2.06%
Department Stores
+2.05%
Leisure
+2.01%
Independent Power Producers
+1.93%
Silver
+1.85%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for ANEB.

Peers

No peer list available for ANEB.

Total assets

—

Total debt

—

Cash & equiv

—

Operating CF

—

Free cash flow

—

Buybacks

—

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin